Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

CD44 signaling in skin wound healing and regeneration

Guan AY., Chen Y., Tseng SC., Lin Q.

Narrative Review on Chronic Wound, Scar, published in J Transl Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Transl Med (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40775777
PMCID
PMC12329881
DOI
10.1186/s12967-025-06913-5
Citations
13

Abstract (original English)

Post-natal skin wound healing results in scar formation. Current therapies for treating or preventing scarring, especially for hypertrophic scars (HTS), often yield unsatisfactory results. The development of HTS can result from dysfunction in the four overlapping phases of wound healing, particularly during the inflammatory phase. The injury induces upregulations of Cluster of Differentiation 44 (CD44) receptor and its primary and most specific ligand hyaluronic acid (HA). This suggests that CD44 signaling may play an important role in post-natal wound healing. In this comprehensive review, we summarize and compare, for the first time, the roles of CD44 signaling triggered by HA of different molecular weights in skin wound healing. Notably, we discuss a new paradigm to activate CD44's pro-regenerative properties in wound healing through the heavy chain-hyaluronan/Pentraxin 3 (HC-HA/PTX3), a complex that contains HA derived from human amniotic membrane. CD44 is involved throughout the four phases of skin wound healing: hemostasis, inflammation, proliferation, and remodeling. Importantly, CD44 signaling initiated by ligands may differently regulate the phenotypic and functional plasticity of various immune cells in wound inflammation. During wound remodeling, CD44 also exhibits immunoregulatory effects on keratinocytes and epithelial cells in re-epithelialization, vascular endoth

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
SkinAnimalsHumansInflammationHyaluronic AcidRegenerationWound HealingSignal TransductionHyaluronan Receptors

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research